ClearPoint Neuro CLPT Product — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's product — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's product — revenue?
- ClearPoint Neuro (CLPT) reported product — revenue of $8.8M in Q1 2026.
- How has ClearPoint Neuro's product — revenue changed year-over-year?
- ClearPoint Neuro's product — revenue increased by 66.4% year-over-year, from $5.29M to $8.8M.
- What is the long-term trend for ClearPoint Neuro's product — revenue?
- Over 4 years (2021 to 2025), ClearPoint Neuro's product — revenue has grown at a 19.0% compound annual growth rate (CAGR), from $11.91M to $23.86M.
- What does product — revenue mean?
- This metric represents the total gross revenue generated from the sale of medical device hardware and associated physical products within the specified business segment. It reflects the company's ability to monetize its core surgical platform and related equipment offerings. Growth in this figure indicates successful market penetration and adoption of the company's proprietary technology by clinical facilities.